Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Guangzhou Jet Biofiltration CoSHSE:688026 +0.74%67 PB Ratio is 1.44 as of Jul. 29, 2026, which is 41% below its 10-year median of 2.46. GuruFocus rates SHSE:688026 with a GF Score™ of 67/100 and a GF Value™ of ¥18.12 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Guangzhou Jet Biofiltration Co ranks better than 64.93% on this metric.
Guangzhou Jet Biofiltration Co Ltd stock PB Ratio (=1.36) is close to 2-year low of 1.27.
The historical rank and industry rank for Guangzhou Jet Biofiltration Co's PB Ratio or its related term are showing as below:
SHSE:688026'
s PB Ratio Range Over the Past 10 Years
Min: 1.14 Med: 2.46 Max: 20.49
Current: 1.44
During the past 13 years, Guangzhou Jet Biofiltration Co's highest PB Ratio was 20.49. The lowest was 1.14. And the median was 2.46.
SHSE:688026's PB Ratio is ranked better than 64.93% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs SHSE:688026: 1.44
During the past 12 months, Guangzhou Jet Biofiltration Co's average Book Value Per Share Growth Rate was -1.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 2.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 8.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 16.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Guangzhou Jet Biofiltration Co was 34.80% per year. The lowest was 2.20% per year. And the median was 18.75% per year.
Back to Basics: PB Ratio
Guangzhou Jet Biofiltration Co (SHSE:688026) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Guangzhou Jet Biofiltration Co PB Ratio Related Terms
Guangzhou Jet Biofiltration Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688026 vs ISRG, BDX, MDLN: PB Ratio Comparison
For the Medical Instruments & Supplies subindustry, Guangzhou Jet Biofiltration Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangzhou Jet Biofiltration Co PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Guangzhou Jet Biofiltration Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Guangzhou Jet Biofiltration Co's PB Ratio falls into.
Guangzhou Jet Biofiltration Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Guangzhou Jet Biofiltration Co (SHSE:688026) has a PB Ratio of 1.44 as of Jul. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Guangzhou Jet Biofiltration Co and its competitors. This is 41% below median its historical median of 2.46. Over the past decade, Guangzhou Jet Biofiltration Co's PB Ratio has ranged from 1.14 to 20.49. According to the industry distribution chart, Guangzhou Jet Biofiltration Co ranks #276 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 35.1%.
Is Guangzhou Jet Biofiltration Co's PB Ratio too high?
Guangzhou Jet Biofiltration Co's current PB Ratio of 1.44 is 41% below median its 10-year median of 2.46. Over the past 10 years, this metric has ranged from a low of 1.14 to a high of 20.49. The Medical Devices & Instruments industry median PB Ratio is 2.04. Guangzhou Jet Biofiltration Co's value of 1.44 is 29.4% below this industry median. Based on the distribution chart, Guangzhou Jet Biofiltration Co ranks #276 out of 787 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Guangzhou Jet Biofiltration Co has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Jet Biofiltration Co's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Guangzhou Jet Biofiltration Co ranks #276 out of 787 companies for PB Ratio. This puts Guangzhou Jet Biofiltration Co in the upper half of its industry. The industry median PB Ratio is 2.04. Guangzhou Jet Biofiltration Co's value of 1.44 is 29.4% below this benchmark. Historically, Guangzhou Jet Biofiltration Co's own PB Ratio has ranged from 1.14 to 20.49 over the past decade. While the company's 10-year median is 2.46 vs. the industry median of 2.04, Guangzhou Jet Biofiltration Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.04, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangzhou Jet Biofiltration Co's current PB Ratio of 1.44 is 29.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Guangzhou Jet Biofiltration Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangzhou Jet Biofiltration Co's current PB Ratio is 1.44, which is 41% below median its own 10-year median of 2.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Jet Biofiltration Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Jet Biofiltration Co (SHSE:688026) is currently considered Possible Value Trap. The stock's GF Value™ is ¥18.12, compared to a current price of ¥12.20 — trading 32.7% below its estimated fair value. The current PB Ratio is 1.44, which is 41% below median its 10-year median of 2.46 and 29.4% below the Medical Devices & Instruments industry median of 2.04. Guangzhou Jet Biofiltration Co's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Guangzhou Jet Biofiltration Co (SHSE:688026), the current PB Ratio is 1.44 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangzhou Jet Biofiltration Co (SHSE:688026) Overvalued in 2026?
Based on GuruFocus' analysis, Guangzhou Jet Biofiltration Co stock appears to be undervalued.
The current stock price of ¥12.20 is trading 32.7% below its estimated GF Value™ of ¥18.12.
GuruFocus considers Guangzhou Jet Biofiltration Co to be Possible Value Trap.
Key valuation signals for SHSE:688026:
PB Ratio: 1.44 (41% below median its 10-year median of 2.46)
GF Value™: ¥18.12 vs. price of ¥12.20 (32.7% below fair value)
Industry Position: 29.4% below the Medical Devices & Instruments median (#276 of 787)
No single metric tells the full story. See the SHSE:688026 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangzhou Jet Biofiltration Co Business Description
Guangzhou Jet Biofiltration Co Ltd is engaged in the research and development, manufacturing and sales of laboratory consumable products. Its main products include laboratory consumables (pipettes, tissue culture products, centrifuge tubes, filtration products) analyzer, lab equipment and others.
67GF Score
Get the complete analysis for SHSE:688026
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688026 has been successfully added to your 
